Newly rising knowledge counsel the Pfizer-BioNTech Covid vaccine works considerably much less nicely at stopping an infection and hospitalizations in youngsters aged 5 to 11 than it does in these aged 12 to 17 — a discovering that’s elevating questions on whether or not the businesses selected the fallacious dose for the youthful youngsters.
The information, from New York state, present a speedy and substantial decline in safety after vaccination in youngsters within the youthful age group, with efficacy in opposition to infections dropping off extra rapidly and dramatically than the declines seen in youngsters aged 12 to 17. The research additionally discovered a major, however much less steep, decline in safety in opposition to hospitalizations.
Learn the remainder…